Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Psychiatry Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psychres.2016.09.029PMID 27863321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia

  2016influential reference
• Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

  2016cited by this paper
• Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review.

  2015cited by this paper
• Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy.

  2015cited by this paper
• Systematic Review and Meta-Analysis of Circulating S100B Blood Levels in Schizophrenia

  2014cited by this paper
• Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.

  2014cited by this paper
• Chronic nicotine improves short‐term memory selectively in a G72 mouse model of schizophrenia

  2014cited by this paper
• The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.

  2014cited by this paper
• The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness.

  2014cited by this paper
• Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder.

  2014cited by this paper
• The Serum Concentration of the Calcium Binding Protein S100B is Positively Associated with Cognitive Performance in Older Adults

  2013cited by this paper
• Levels of S100B are raised in female patients with schizophrenia

  2013cited by this paper
• Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia

  2013cited by this paper
• Biomarkers of cognitive dysfunction in traumatic brain injury

  2013cited by this paper
• Serum S100B Represents a New Biomarker for Mood Disorders

  2013cited by this paper
• Cognition in schizophrenia: core psychological and neural mechanisms.

  2012cited by this paper
• [Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness].

  2012cited by this paper
• Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels.

  2012cited by this paper
• Risk variants in the S100B gene, associated with elevated S100B levels, are also associated with visuospatial disability of schizophrenia.

  2011influential reference
• Usefulness of S100B protein in neurological disorders.

  2011cited by this paper
• Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis

  2011cited by this paper
• S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research.

  2010cited by this paper
• Extracranial Sources of S100B Do Not Affect Serum Levels

  2010cited by this paper
• Increased serum S100B in never-medicated and medicated schizophrenic patients.

  2010cited by this paper
• ncreased serum S 100 B levels in chronic schizophrenic patients on long-term lozapine or typical antipsychotics

  2009cited by this paper
• Clinical reliability and validity of the Chinese version of Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery

  2009cited by this paper
• Cognitive Remediation in Schizophrenia

  2009cited by this paper
• Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia.

  2008cited by this paper
• The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

  2008cited by this paper
• Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.

  2008cited by this paper
• Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

  2007cited by this paper
• Evidence for a wide extra-astrocytic distribution of S100B in human brain

  2007cited by this paper
• S100B in neuropathologic states: The CRP of the brain?

  2007cited by this paper
• Effects of Nicotine Nasal Spray on Cognitive Function in Schizophrenia

  2006cited by this paper
• Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF

  2004cited by this paper
• Nicotine improves delayed recognition in schizophrenic patients

  2004cited by this paper
• Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

  2004cited by this paper
• Effects of Nicotine on Cognitive Deficits in Schizophrenia

  2004cited by this paper
• S100B in brain damage and neurodegeneration

  2003cited by this paper
• Glial protein S100B modulates long-term neuronal synaptic plasticity

  2002cited by this paper
• Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology

  2001cited by this paper
• S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.

  2001cited by this paper
• S100β Stimulates Inducible Nitric Oxide Synthase Activity and mRNA Levels in Rat Cortical Astrocytes (*)

  1996cited by this paper
• The S100 family of EF-hand calcium-binding proteins: functions and pathology.

  1996cited by this paper
• The S100 protein family: history, function, and expression.

  1995cited by this paper

• Salivary Biomarkers as a Predictive Factor in Anxiety, Depression, and Stress

  2025cites this paper
• Astrocytic abnormalities in brain-specific Cacna1c-deficient mice: Implications for BBB impairment in neuropsychiatric diseases associated with CACNA1C mutations

  2025cites this paper
• The role of tight junction proteins in the pathogenesis of schizophrenia.

  2025cites this paper
• Blood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions

  2025cites this paper
• Changes in S100 calcium-binding protein β (S100β) and cognitive function from pre- to post-chemotherapy among women with breast cancer

  2024cites this paper
• Probiotic Formulation for Patients With Bipolar or Schizophrenia Spectrum Disorder: A Double-Blind, Randomized Placebo-Controlled Trial

  2024cites this paper
• Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review

  2023influential citation
• Vascular-related biomarkers in psychosis: a systematic review and meta-analysis

  2023cites this paper
• Predictive effect of Bayes discrimination in the level of serum protein factors and cognitive dysfunction in schizophrenia.

  2022cites this paper
• Systematic Review and Meta-Analysis of Damage Associated Molecular Patterns HMGB1 and S100B in Schizophrenia

  2022cites this paper
• Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients.

  2022cites this paper
• Faulty fences: Blood-brain barrier dysfunction in schizophrenia

  2022cites this paper
• Correlation of BDNF, VEGF, TNF‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients

  2022cites this paper
• Abnormal synaptic plasticity and impaired cognition in schizophrenia

  2022cites this paper
• Toxoplasma Seropozitif ve Seronegatif Şizofreni Hastalarında S100B Proteininin Değerlendirilmesi

  2021cites this paper
• Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice.

  2021cites this paper
• Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrations.

  2021cites this paper
• Correlation between S100B and severity of depression in MDD: A meta-analysis

  2021cites this paper
• PACIENTES INGRESADOS POR RECAÍDA AGUDA DE ESQUIZOFRENIA PARANOIDE: CAMBIOS ESTACIONALES, PERO NO CIRCADIANOS, EN LOS NIVELES SÉRICOS DE PROTEÍNA S100B

  2021cites this paper
• Disruption of the blood-brain barrier in 22q11.2 deletion syndrome.

  2021cites this paper
• Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions

  2020cites this paper
• S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders.

  2020cites this paper
• Different serum protein factor levels in first‐episode drug‐naive patients with schizophrenia characterized by positive and negative symptoms

  2020cites this paper
• Blood-brain barrier regulation in psychiatric disorders.

  2020cites this paper
• Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies

  2020cites this paper
• Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia.

  2019cites this paper
• More dampened monocytic Toll-like receptor 4 response to lipopolysaccharide and its association with cognitive function in Chinese Han first-episode patients with schizophrenia.

  2019cites this paper
• Serum levels of oxidants and protein S100B were associated in the first-episode drug naïve patients with schizophrenia

  2019cites this paper
• A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis

  2018cites this paper
• Resting-state Brain Activity Changes Associated with Tardive Dyskinesia in Patients with Schizophrenia: Fractional Amplitude of Low-frequency Fluctuation Decreased in the Occipital Lobe.

  2018cites this paper
• Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia

  2018cites this paper
• Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia

  2017influential citation
• Oxygen Supplementation Improves Protein Milieu Supportive of Protein Synthesis and Antioxidant Function in the Cortex of Alzheimer’s Disease Model Mice—a Quantitative Proteomic Study

  2017cites this paper
• The Insertion of Electrodes in the Brain for Electrophysiological Recording or Chronic Stimulation Is Not Associated With Any Biochemically Detectable Neuronal Injury

  2017influential citation